Open access · CC-BY
via OpenAlex
Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model
Zhenye Zhu, M. Lei, Ruizhi Guo, Yining Xu, Yanqing Zhao, Chenlu Wei, Qingling Yang, Yingpu Sun
Journal of Ovarian Research · 2025 · ▲ 11 citations
Abstract
Polycystic ovary syndrome (PCOS) is the leading cause of anovulatory infertility among women of reproductive age, yet the range of effective treatment options remains limited. Our previous study revealed that reduced levels of nicotinamide adenine dinucleotide (NAD+) in ovarian granulosa cells (GCs) of women with PCOS resulted in the accumulation of reactive oxygen species (ROS) and mitochondrial dysfunction(definition). However, it is still uncertain whether increasing NAD+ levels in the ovaries could improve ovarian function in PCOS. In this study, we demonstrated that supplementation with the NAD+ precursor nicotinamide riboside (NR) prevented the decrease in ovarian NAD+ levels, normalized estrous cycle irregularities, and enhanced ovulation potential in dehydroepiandrosterone (DHEA)-induced PCOS mice. Moreover, NR supplementation alleviated ovarian fibrosis and enhanced mitochondrial function in ovarian stromal cells of PCOS mice. Furthermore, NR supplementation improved oocyte quality in PCOS mice, as evidenced by reduced abnormal mitochondrial clustering, enhanced mitochondrial membrane potential, decreased ROS levels, reduced spindle abnormality rates, and increased early embryonic development potential in fertilized oocytes. These findings suggest that supplementing with NAD+ precursors could be a promising therapeutic strategy for addressing ovarian infertility associated with PCOS. Ovarian NAD+ levels decreased in DHEA-induced PCOS mice, accompanied by mitochondrial dysfunction in oocytes and ovarian stromal cells, resulting in reduced oocyte quantity and quality, decreased early embryonic development potential, and increased ovarian fibrosis. After increasing ovarian NAD+ levels by NR supplementation to restore PCOS-related impairment of mitochondria function, ovarian dysfunction in PCOS was attenuated as characterized by improved oocyte quantity and quality, enhanced early embryonic development potential, and decreased ovarian fibrosis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13048-025-01596-4
- Canonical
- link ↗
- Fetched
- 2026-07-27 MST
Cite this
APA
Zhu, Z., Lei, M., Guo, R., Xu, Y., Zhao, Y., Wei, C., Yang, Q., & Sun, Y. (2025). Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model. <em>Journal of Ovarian Research</em>. https://doi.org/10.1186/s13048-025-01596-4
Vancouver
Zhu Z, Lei M, Guo R, Xu Y, Zhao Y, Wei C, et al. Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model. Journal of Ovarian Research. 2025. doi:10.1186/s13048-025-01596-4.
BibTeX
@article{zhenye2025Nicoti,
title = {Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model},
author = {Zhenye Zhu and M. Lei and Ruizhi Guo and Yining Xu and Yanqing Zhao and Chenlu Wei and Qingling Yang and Yingpu Sun},
journal = {Journal of Ovarian Research},
year = {2025},
doi = {10.1186/s13048-025-01596-4},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Reproduction 2025
Open access · CC-BY
Nicotinamide riboside supplementation protects against maternal diabetes-associated decline in oocyte quality
Aging Cell 2023
Open access · CC-BY
Deletion of enzymes for de novo NAD + biosynthesis accelerated ovarian aging
Investigative Ophthalmology & Visual Science 2024
Open access · CC-BY
Protective Effect of Nicotinamide Riboside on Glucocorticoid-Induced Glaucoma: Mitigating Mitochondrial Damage and Extracellular Matrix Deposition
Journal of Food Biochemistry 2026
Open access · CC-BY
Nicotinamide Riboside Improves Mitochondrial Function and Oocyte Maturation in Aged Mice: A Multitarget Mechanistic Study Using Network Pharmacology and Molecular Simulations
IUBMB Life 2008
Open access · OA
Brain mitochondrial dysfunction in aging
Antioxidants 2024
Open access · CC-BY